Project cooperationUpdated on 12 January 2026
Advanced 3D-Printed Biomaterial and Bioink Platforms for Disease-Specific cellular models
BioProducts R&D Manager | Regulatory Compliance Officer at COLFEED4Print
Madrid, Spain
About
COLFEED seeks partners to co-develop next-generation organoid platforms using functionalized, easy-to-print biomaterial feedstocks and bioinks for New Approach Methodologies (NAMs) in biomedical research and regulatory drug testing.
COLFEED is a biomaterials manufacturer specializing in 3D printing feedstocks for FDM, with:
-
Patented technology for functionalized, easy-to-print biomaterials
-
Strong experience translating materials into clinical and hospital environments
-
Active collaborations with hospital-based 3D printing units for point-of-care manufacturing
-
Expertise in scalability, reproducibility and manufacturability, key for regulatory acceptance
Within the consortium, COLFEED can lead or contribute to:
-
Development of printing-grade biomaterials and bioinks
-
Design of organoid-supportive scaffolds and matrices
-
Integration of manufacturing workflows compliant with regulatory expectations
-
Technology transfer toward clinical and industrial environments
Partners may contribute to organoid biology, analytical validation, disease modeling, clinical relevance or regulatory alignment.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Similar opportunities
Project cooperation
Climate-Neutral Point-of-Care 3D Printed Regenerative Bone Implants for Resilient Healthcare Systems
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
Lucia Gallego
BioProducts R&D Manager | Regulatory Compliance Officer at COLFEED4Print
Madrid, Spain
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Oscar Castano
Tenured Associate Professor at Universitat de Barcelona
Barcelona, Spain
Project cooperation
Organoids and bionanomaterials customization
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Fabrizio Gelain
PI at IRCCS Casa Sollievo della Sofferenza
San Giovanni Rotondo, Italy